← Back to Patent Explorer
US4224408A Expired / Lapsed US ⏱️ 0.0 years remaining

Deoxyribonucleic acid synthesis using binding protein

Assignee: Abbott Laboratories
•
Filing: 1978-11-22
•
Granted: 1980-09-23
•
Expires: 1998-11-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Described is a method of obtaining complete copying of the entire length of single stranded ribonucleic acid (RNA) into its complementary deoxyribonucleic acid (cDNA) by reverse transcription using binding protein. The method can be used in recombinant DNA research to copy total messenger RNA into DNA.

Inventors

  • 👤 Paul P. Hung
  • 👤 Shaw-guang Lee

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 05:43
CPC Classifications
C; C12; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1096

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 76 words
A method of reverse transcription of the total length of a single stranded ribonucleic acid (RNA) such as Rous sarcoma virus RNA into its complementary deoxyribonucleic acid (cDNA), said method comprising: incubating Rous sarcoma virus ribonucleic acid in the presence of reverse transcriptase, and nucleic acid binding protein devoid of nuclease activity and isolated from Rous sarcoma virus transformed chicken embryonic fibroblast or untransformed chick embryonic fibroblasts and actinomycin D, and isolating the deoxyribonucleic acid product.
Claim 2
Independent Claim 76 words
A method of reverse transcription of the total length of a single stranded ribonucleic acid (RNA) such as Rous sarcoma virus RNA into its complementary deoxyribonucleic acid (cDNA), said method comprising: incubating Rous sarcoma virus ribonucleic acid in the presence of reverse transcriptase, and nucleic acid binding protein devoid of nuclease activity and isolated from Rous sarcoma virus transformed chicken embryonic fibroblast or untransformed chick embryonic fibroblasts and actinomycin D, and isolating the deoxyribonucleic acid product.
Claim 3
Dependent Claim 21 words
The method of claim 1 wherein the deoxyribonucleic acid product is isolated by gel filtration chromatography and electrophoresis of the product.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-09-23 1984-03-24 1984-09-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-09-23 1988-03-24 1988-09-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-09-23 1992-03-24 1992-09-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag